NJBK(SH:601009) Jiang Nan Shi Bao·2025-03-28 06:41Core Insights - Nanjing Bank has launched an innovative financial product called "R&D Pipeline Loan" in collaboration with the National University Biomedicine Regional Technology Transfer Center, aimed at supporting early-stage biopharmaceutical projects that struggle to secure traditional bank loans due to long R&D cycles and high costs [1][5] - The first loan of 5 million yuan was approved and disbursed within two weeks, demonstrating the efficiency of the bank's approval process and its commitment to facilitating the transformation of scientific achievements into tangible assets [1][3] Group 1 - The "R&D Pipeline Loan" is specifically designed for startup R&D enterprises within the biopharmaceutical sector, addressing their medium to long-term funding needs [1][3] - The loan incorporates a pipeline assessment mechanism to evaluate the market value and progress of ongoing projects, enhancing the likelihood of successful commercialization [3] - The initiative marks a significant step for Nanjing Bank in promoting innovation within the biopharmaceutical industry, with plans to continue exploring innovative financial service models to support technology transformation [5]